A phase II study of bortezomib in the treatment of metastatic malignant melanoma

Svetomir N. Markovic, Susan M. Geyer, Fitzroy Dawkins, William Sharfman, Mark Albertini, William Maples, Paula M. Fracasso, Tom Fitch, Patricia LoRusso, Alex A. Adjei, Charles Erlichman

Research output: Contribution to journalArticle

123 Scopus citations

Fingerprint Dive into the research topics of 'A phase II study of bortezomib in the treatment of metastatic malignant melanoma'. Together they form a unique fingerprint.

Medicine & Life Sciences